Company news

Rain Enhancement Technologies Holdco, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments

February 7, 2022

Rain Therapeutics Doses First Patient in Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)

November 18, 2021

Rain Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Progress

November 9, 2021

Rain Therapeutics Initiates Phase 3 MANTRA Clinical Trial of Milademetan for De-differentiated Liposarcoma and Provides Patient Update from Prior Clinical Program

July 19, 2021

Rain Therapeutics Announces Collaboration with Tempus for Genomic Analysis in Planned MDM2-Amplified Phase 2 Basket Trial of RAIN-32

June 2, 2021

Rain Therapeutics Announces Patient Referral Partnership for the Planned MDM2-Amplified Phase 2 Basket Trial of RAIN-32

June 1, 2021

Rain Therapeutics Appoints Robert Doebele, M.D., Ph.D. as President

May 19, 2021

← Newer news releases

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 10 decks. Every deck is listed under its year.